Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin effect on supraventricular arrhythmias
IRCT20240116060704N1Phase 3Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of empagliflozin in Supraventricular arrhythmia (SVA), sponsored by Baqiyatallah University of Medical Sciences. Started Feb 2024; status: completed.
02
Drugs
empagliflozin
03
Conditions
Supraventricular arrhythmia (SVA)
Beyond the preview
Go deeper on IRCT20240116060704N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240116060704N1.